Followers | 505 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
![](https://investorshub.advfn.com/uicon/475374.png?cb=1683825270)
Friday, December 11, 2015 3:51:15 PM
bullish 6.35
resistance breakout
## source: finance.yahoo.com
Thu, 10 Dec 2015 13:59:36 GMT ~ Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
[at noodls] - CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ: CERS) announced today that the National Transfusiology Center (NTC) of Mongolia has signed a purchase agreement for the INTERCEPT Blood System ...
read full: http://www.noodls.com/view/EE0EDB937A498D46A55571A20750D9E286DA1789
*********************************************************
Thu, 10 Dec 2015 13:32:00 GMT ~ Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
[Business Wire] - CONCORD, Calif.--(BUSINESSWIRE)-- Cerus Corporation (NASDAQ: CERS) announced today that the National Transfusiology Center (NTC) of Mongolia has signed a purchase agreement for the INTERCEPT Blood System ...
read full: http://au.finance.yahoo.com/news/cerus-announces-agreement-national-transfusiology-133200634.html
*********************************************************
Thu, 10 Dec 2015 13:32:00 GMT ~ Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
[Business Wire] - Cerus Corporation announced today that the National Transfusiology Center of Mongolia has signed a purchase agreement for the INTERCEPT Blood System for platelets and plasma.
read full: http://finance.yahoo.com/news/cerus-announces-agreement-national-transfusiology-133200550.html
*********************************************************
Wed, 09 Dec 2015 13:43:29 GMT ~ Cerus Announces Agência Nacional de Vigilância Sanitária Approval of the INTERCEPT Blood System for Platelets and Plasma in Brazil
[at noodls] - CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ:CERS) today announced that the INTERCEPT Blood System for platelets and plasma has been approved for commercialization in Brazil by the Agência ...
read full: http://www.noodls.com/view/585BA11D6BE9AF332EC8A9E39B2EC6DD03843629
*********************************************************
Wed, 09 Dec 2015 13:35:00 GMT ~ 8:35 am Cerus announces that the INTERCEPT Blood System for platelets and plasma has been approved for commercialization in Brazil by the Agncia Nacional de Vigilncia Sanitria
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#cers
*********************************************************
$CERS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CERS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CERS/company-info
Ticker: $CERS
OTC Market Place: Not Available
CIK code: 0001020214
Company name: Cerus Corp.
Incorporated In: DE, USA
$CERS share structure
## source: otcmarkets.com
Market Value: $603,712,850 a/o Dec 10, 2015
Shares Outstanding: 97,138,029 a/o Oct 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$CERS extra dd links
Company name: Cerus Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CERS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CERS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CERS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CERS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CERS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/news - http://finance.yahoo.com/q/h?s=CERS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CERS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CERS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CERS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CERS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CERS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CERS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Cerus+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Cerus+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Cerus+Corp.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CERS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CERS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CERS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CERS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CERS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001020214&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CERS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CERS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CERS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CERS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CERS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CERS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CERS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CERS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CERS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CERS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CERS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CERS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CERS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CERS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CERS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CERS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CERS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CERS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CERS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CERS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CERS
$CERS DD Notes ~ http://www.ddnotesmaker.com/CERS
Recent CERS News
- Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors • Business Wire • 07/02/2024 08:00:00 PM
- Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion • Business Wire • 06/21/2024 12:30:00 PM
- Cerus Corporation Celebrates World Blood Donor Day 2024 • Business Wire • 06/14/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:03:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 12:03:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 12:02:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 12:00:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:59:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:58:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:57:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:54:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:52:59 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 08:01:50 PM
- Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference • Business Wire • 05/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 10:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 09:09:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2024 12:17:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 09:15:17 PM
- Cerus Corporation Announces First Quarter 2024 Financial Results • Business Wire • 05/02/2024 08:00:00 PM
- Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024 • Business Wire • 04/18/2024 12:30:00 PM
- Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life • Business Wire • 03/26/2024 12:30:00 PM
- Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients • Business Wire • 03/19/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:46:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:22:00 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM